<DOC>
	<DOCNO>NCT02219191</DOCNO>
	<brief_summary>To evaluate Effect Puerarin tablet versus statin treat metabolism syndrome patient chronic rheumatic disease</brief_summary>
	<brief_title>Puerarin Versus Atorvastatin Treating Metabolism Syndrome Patients With Chronic Rheumatic Diseases</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Rheumatic Diseases</mesh_term>
	<mesh_term>Collagen Diseases</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<mesh_term>Puerarin</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<criteria>patient definite diagnose rheumatic disease patient metabolic Syndrome without conflict write , informed consent sign prior enrollment severe hepatic renal disorder know carotid artery stenosis coagulation disorder hypertension pregnancy , lactation period pregnancy plan allergic test drug compatible trial medication without full legal capacity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Puerarin tablet</keyword>
	<keyword>rheumatoid arthritis</keyword>
	<keyword>metabolism syndrome</keyword>
</DOC>